Libros bestsellers hasta 50% dcto  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Inhaled Medicines: Optimizing Development Through Integration of in Silico, in Vitro and in Vivo Approaches (in English)
Type
Physical Book
Publisher
Year
2021
Language
English
Pages
438
Format
Paperback
Dimensions
23.1 x 19.1 x 2.3 cm
Weight
0.88 kg.
ISBN13
9780128149744
Edition No.
1

Inhaled Medicines: Optimizing Development Through Integration of in Silico, in Vitro and in Vivo Approaches (in English)

Stavros Kassinos (Illustrated by) · Per Backman (Illustrated by) · Joy Conway (Illustrated by) · Academic Press · Paperback

Inhaled Medicines: Optimizing Development Through Integration of in Silico, in Vitro and in Vivo Approaches (in English) - Kassinos, Stavros ; Backman, Per ; Conway, Joy

Physical Book

$ 183.38

$ 305.64

You save: $ 122.26

40% discount
  • Condition: New
Origin: United Kingdom (Import costs included in the price)
It will be shipped from our warehouse between Monday, June 17 and Thursday, June 27.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Inhaled Medicines: Optimizing Development Through Integration of in Silico, in Vitro and in Vivo Approaches (in English)"

Inhaled medicines are widely used to treat pulmonary and systemic diseases. The efficacy and safety of these medicines can be influenced by the deposited fraction, the regional deposition pattern within the lungs and by post-depositional events such as drug dissolution, absorption and clearance from the lungs. Optimizing performance of treatments thus requires that we understand and are able to quantify these product and drug attributes. Inhaled Medicines: Optimizing Development through Integration of In Silico, In Vitro and In Vivo Approaches explores the current state of the art with respect to inhalation drug delivery, technologies available to assess product performance, and novel in silico methods now available to link in vitro product performance to clinical performance. Recent developments in the latter field, especially the prospect of integration of three-dimensional Computational Fluid Particle Methods (3D-CFPD) with physiologically based pharmacokinetic (PBPK models), unlocks the potential for in silico population studies that can help inform and optimize treatment and product development strategies. In this highly multidisciplinary field, where progress occurs at the intersection of several disciplines of engineering and science, this work aims to integrate current knowledge and understanding and to articulate a clear vision for future developments.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews